Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancers (BTC)”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Testing effectiveness (Phase 2)Looking for participantsNCT06413745
What this trial is testing

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

Who this might be right for
HER2 Expression / Amplification in Patients With Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd. 65
Testing effectiveness (Phase 2)Study completedNCT03778593
What this trial is testing

FOLFIRINOX for 2nd-line Treatment of BTC

Who this might be right for
Biliary Tract Cancer
Dong-A University Hospital 34
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Not applicableLooking for participantsNCT06648057
What this trial is testing

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
CHA University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07159204
What this trial is testing

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07398339
What this trial is testing

Cosiporfin Sodium for Injection Photodynamic Therapy

Who this might be right for
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd 30
Large-scale testing (Phase 3)Looking for participantsNCT06467357
What this trial is testing

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
AstraZeneca 620
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919848
What this trial is testing

Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)

Who this might be right for
Biliary Tract Cancer (BTC)
Fudan University 74
Testing effectiveness (Phase 2)Ended earlyNCT04784520
What this trial is testing

HA121-28 Tablets in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07099794
What this trial is testing

A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Who this might be right for
Biliary Tract Cancer (BTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 90
Testing effectiveness (Phase 2)Study completedNCT03937895
What this trial is testing

Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
SMT bio Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Who this might be right for
Cancer
Novartis Pharmaceuticals 206
Testing effectiveness (Phase 2)Study completedNCT03486678
What this trial is testing

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
The First Affiliated Hospital with Nanjing Medical University 38
Testing effectiveness (Phase 2)Study completedNCT02579616
What this trial is testing

Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy

Who this might be right for
Biliary Tract Cancer
Eisai Co., Ltd. 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07351591
What this trial is testing

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
Eastern Hepatobiliary Surgery Hospital 88
Large-scale testing (Phase 3)Active Not RecruitingNCT03875235
What this trial is testing

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

Who this might be right for
Biliary Tract Neoplasms
AstraZeneca 810
Testing effectiveness (Phase 2)Study completedNCT04217954
What this trial is testing

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Who this might be right for
Advanced Biliary Tract Cancer
Peking University 32
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT03092895
What this trial is testing

SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Who this might be right for
Advanced Primary Liver CancerAdvanced Biliary Tract Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 157
Large-scale testing (Phase 3)Study completedNCT04003636
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 1,069
Load More Results